genekor

19 September, 2023

prime DX: A New Era in Personalized Cancer Treatment!

prime DXThe prime DX assay provides a detailed blueprint of tumor biology, which is used by the physician to design the most effective individualized treatment plan for the patient.It includes […]

26 July, 2023

W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer.

W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer. The company Genekor actively […]

26 May, 2023

Genekor’s presence at the ASCO 2023 Annual Conference

3 Scientific Papers have been accepted by ASCO, to be presented at this year’s conference in June. Genekor scientists, Hospitals and Doctors participated in the investigations, presenting substantial findings concerning […]

17 May, 2023

7th Health Innovation Conference 2023

. Nikos Tsoulos MSc, MBA, PhDc, Biochemist, CEO, GeneKor Medical SA gave a speech entitled “The present and future of biomarkers in the Greek health system” he stated that today, […]

8 May, 2023

29th Hellenic Congress of Clinical Oncology (29th ESKO)

In the context of the 29th Hellenic Congress of Clinical Oncology (29th ESKO) held on April 5-8, 2023 in Athens at the Athenaeum Intercontinental Hotel, Genekor played an active role. […]

4 April, 2023

The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine

The outcome of the Study was that information obtained from genetic analysis, especially from an integrated NGS analysis such as WES and WGS, is valuable for the diagnosis and individualized […]

15 March, 2023

CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case report

The new publication of the Genekor Scientific Team on: CNV and RNA analysis reveal a germline pathogenic duplication of MSH2 exon 15 in a family with Lynch syndrome: A case […]

25 January, 2023

Molecular Residual Disease – Publication of the GALAXY Study

On Monday, January 16th, Nature Medicine published the first results of the observational study (GALAXY study), which is one of the 3 arms of the prospective study (CIRCULATE Japan). Important […]

23 December, 2022

70% of relatives of patients with pathogenic genes do not undergo genetic testing

Nikos Tsoulos, CEO of Genekor I.A.E., gave an interview to THE DOCTOR magazine on the importance of genetic testing in relatives of people who have been diagnosed with breast and […]

Search